Phase 1, Open-Label, Randomized, Single-Dose, 3-Way Crossover Study Assessing Bioequivalence Of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition.
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2011
At a glance
- Drugs Doxazosin (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 07 Sep 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2011 New trial record